PHIA Koninklijke Philips N.V.

Survey cites enhanced patient experience and anxiety reduction as top benefits of Philips Ambient Experience

Survey cites enhanced patient experience and anxiety reduction as top benefits of Philips Ambient Experience

March 3, 2021

  • 2000th customer installation of Philips Ambient Experience at bdz Bilddiagnostisches Zentrum Münster in Germany
  • 91% of surveyed users are likely or extremely likely to recommend Philips Ambient Experience to other hospitals

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the 2000th installation of its revolutionary patient-centric , together with the results of a comprehensive customer survey that reveals 91% of users are likely, or extremely likely, to recommend Philips Ambient Experience to other hospitals. The survey also further confirms the solution’s ability to help hospitals deliver on the quadruple aim of enhanced patient and staff experiences, better outcomes, and lower cost of care. Philips’ 2000th Ambient Experience install started at the bdz Bilddiagnostisches Zentrum Münster in Germany, as an integral part of the diagnostic center's newly equipped radiology suite.

Philips Ambient Experience solution is a unique combination of optimized design, site planning, proprietary software, lighting, sound, video projection and multimedia content that applies human-focused innovation and design thinking to offer hospital patients and staff an engaging and pleasant experience. It can be applied both in radiology exam/treatment rooms and peripheral areas such as reception areas and waiting rooms.

The majority of survey respondents indicate that Ambient Experience decreases patient tension (76%) and fear (71%), induces patient calmness (66%), and improves cooperation during exams (63%). Ambient Experience is found to have the highest added value for patients with claustrophobia or anxiety, pediatric patients, and patients undergoing longer studies like MRI exams. By helping to improve the patient experience and reducing anxiety, Ambient Experience can help facilitate first-time-right scans and diagnoses to help drive better health outcomes, improved hospital efficiency, and higher patient and staff satisfaction.

“Health systems are looking for ways to increasing patient satisfaction while improving patient throughput and compliance in diagnostic imaging,” said Werner Satter, General Manager Healthcare Experience Solutions at Philips. “Our customers confirm that Ambient Experience helps them improve the patient experience, reducing the patient’s anxiety and thereby increasing first-time-right imaging.”

Customer survey results across Europe and the U.S.

Analysis of the information provided by 59 respondents across Europe and the U.S. to a customer survey, conducted on behalf of Philips by The MarkeTech Group, indicate improved patient experience (endorsed by 83% of respondents) to be their most valuable attribute of using Ambient Experience in radiology exam rooms. The majority of customers surveyed (83%) indicated that Ambient Experience is at least impactful, and up to extremely impactful, in alleviating patient anxiety.

Based on their current use of the solution, 91% were likely or extremely likely, to recommend their current Ambient Experience offering to another hospital, and 87% were likely, or extremely likely, to include Ambient Experience as part of a new purchase. 75% of respondents in the US and 59% in Europe believe that Ambient Experience encourages patients to choose their facility.

The ability of Ambient Experience to help hospitals deliver on the quadruple aim is also supported by multiple studies across hospital sites in Germany, Denmark and the UK. More information is available in the .

Philips is showcasing its during the European Congress of Radiology (ECR) virtual event (March 3-7, 2021). For more information on Philips’ new portfolio of diagnostic and interventional solutions and AI-enabled applications to enhance radiology workflows at ECR 2021, visit the , and follow for updates throughout the event.

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail :

Twitter:

Mark Groves

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



Attachments



EN
03/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...

 PRESS RELEASE

FDA clears Philips AI solution that provides real-time guidance during...

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2026

Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch